Free Trial
→ Did You See Trump’s Manhattan Project Bombshell? (From Banyan Hill Publishing) (Ad)

PharmChem Q3 2023 Earnings Report

$3.18 +0.02 (+0.71%)
As of 01/21/2025 02:55 PM Eastern
Earnings History

PharmChem EPS Results

Actual EPS
$0.04
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

PharmChem Revenue Results

Actual Revenue
$1.56 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PharmChem Announcement Details

Quarter
Q3 2023
Date
11/2/2023
Time
N/A

Conference Call Resources

PharmChem Earnings Headlines

Cedar Creek Partners Q3 2024 Results
October 24, 2024 | seekingalpha.com
PharmChem, Inc. goes ex dividend tomorrow
October 9, 2024 | msn.com
Trump currency shock imminent
Trump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launched a $1.9 trillion move against the Fed. What comes next could have dramatic consequences.
January 22, 2025 | Stansberry Research (Ad)
Cedar Creek Partners Q2 2024 Results
July 31, 2024 | seekingalpha.com
Getinge AB (publ) (GTN0.F)
July 24, 2024 | finance.yahoo.com
PharmChem, Inc. (PCHM)
May 26, 2024 | finance.yahoo.com
See More PharmChem Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PharmChem? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PharmChem and other key companies, straight to your email.

About PharmChem

PharmChem (OTCMKTS:PCHM) provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.

View PharmChem Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles